Suzolang Biochem Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.21 Cr
About Suzolang Biochem
Suzolang Biochem Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 August 2022 (Two years and six months 11 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.21 Cr.
Pritam Dey, Sudipta Nath, and Indranil Chakraborty serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290WB2022PTC256420
- Company No.
256420
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Suzolang Biochem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudipta Nath  | Managing Director | 17-Aug-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pritam Dey | Director | 15-Dec-2022 | Current |
| Indranil Chakraborty | Director | 17-Aug-2022 | Current |
Financial Performance of Suzolang Biochem.
Enhance accessibility to Suzolang Biochem's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Suzolang Biochem?
Unlock access to Suzolang Biochem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tre Venner Projects LlpSudipta Nath is a mutual person
- Basu Marketing & Manufacturing Company Private Ltd.
Sudipta Nath is a mutual person
- Adytum Impex Private Limited
Indranil Chakraborty is a mutual person
Charges (Loans)
₹22.06 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 2.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2023 | Bank Of India | ₹2.21 Cr | Open |
How Many Employees Work at Suzolang Biochem?
Unlock and access historical data on people associated with Suzolang Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suzolang Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suzolang Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
